GENOMIC HEALTH, INC.

Genomic Health, Inc. specializes in advanced genomic diagnostic testing services, primarily delivering Oncotype DX and related molecular assays to support precision oncology in clinical and military healthcare settings. Their core capabilities center on tumor profiling, RNA-based gene expression analysis, and genomic interpretation for cancer risk stratification—particularly in breast, prostate, and other solid tumors. They provide clinically validated, FDA-recognized laboratory-developed tests that guide treatment decisions in anatomic pathology and oncology workflows, ensuring patient-specific therapeutic recommendations aligned with NCCN guidelines. Their technical expertise includes high-throughput molecular diagnostics, bioinformatics pipelines for genomic data analysis, and compliance with CLIA and CAP standards for clinical laboratories. Differentiators include deep integration of genomic data into care pathways and proven scalability for high-volume, time-sensitive testing environments. The company maintains consistent, long-term relationships with the Department of Defense and the Department of Veterans Affairs, delivering genomic testing services to active-duty personnel, veterans, and military medical facilities. Work for these agencies focuses on enabling personalized cancer care through genomic insights, supporting both frontline clinical decision-making and long-term survivorship programs. Genomic Health, Inc. operates exclusively within the Medical Laboratories (NAICS 621511) sector, positioning itself as a niche provider of molecular diagnostics in government healthcare. Their market focus is on precision oncology services within federal medical systems, where genomic testing is integrated into standard-of-care protocols for cancer management. As a privately held entity headquartered in Redwood City, California, the company operates as a Level 2 business structure with no federal certifications on record. Their geographic presence is centralized, with laboratory operations and clinical support services delivered nationally to federal healthcare networks through secure, accredited diagnostic channels.